Radioimmunoassay
This method combines the specificity of antibody-antigen interactions with the sensitivity of radioactive isotope detection.
Radioimmunoassays involve the use of a radioactively labeled analyte that competes with the unlabeled analyte from the sample for binding to a limited amount of specific antibody.
The amount of radioactive analyte bound to the antibody is inversly proportional to the concentration of the unlabeled analyte in the sample, allowing for accurate quantification.
This powerful technique has numerous applications in clinical diagnostics, pharmacology, and biochemical research, enabling precise measurement of a wide range of target analytes with high sensitivity and specificity.
Leveraging the power of artificial intelligence, researchers can optimize their radioimmunoassay experiments by easily comparing protocols from literature, pre-prints, and patents to identify the best procedures and products for improved reproducibility and accuracy.
Most cited protocols related to «Radioimmunoassay»
Serum corticosterone was measured by radioimmunoassay (MP Biomedicals) from submandibular blood samples obtained directly from the home cage condition or after exploration of a novel box, restraint, or isoflurane exposure. For the dexamethasone suppression test, dexamethasone (Sigma; 50 μg/kg in propylene glycol) or vehicle were injected 90 min prior to restraint, and blood was sampled immediately following 10 min restraint.
Behavioral tests were performed following 30 min of restraint or directly from the home cage. Different cohorts of mice were tested in the NSF test, elevated plus maze, forced swim test and sucrose preference test as previously described.12 (link), 18 (link), 21 , 30 (link) Statistical analyses were performed by t-test, log-rank test, or ANOVA with Fisher's LSD test for post hoc comparisons. Significance was set at P<0.05.
Electrophysiological recordings were carried out as previously reported28 (link). 1-train LTP was induced by a single 100 Hz, 1-second duration train of stimuli. 4-train LTP consisted of 4 trains applied with a 5-minute inter-train interval; for massed 4-train LTP a 5-second inter-train interval was used. Theta-burst stimulation (TBS) consisted of 40-ms duration, 100 Hz bursts delivered at 5 Hz for 3 seconds (15 bursts of 4 pulses per burst, for a total of 60 pulses). Chemical LTP was induced by treatment of slices for 15 minutes with 5µM forskolin (FSK) in 0.1% ethanol, or a combination of 50µM forskolin and 30µM 3-isobutyl-1-methylxanthine (IBMX, in water). Rolipram (0.1µM in 0.1% DMSO) was applied for 60 minutes, beginning 30 minutes before tetanization.
cAMP assays on CA1 regions of hippocampal slices 10 minutes after treatment for 15 minutes with forskolin (50µM), forskolin + IBMX (30µM), or vehicle (0.1% EtOH) were performed by radioimmunoassay according to kit instructions. cAMP-specific PDE activity assays29 (link) and Western blots for PDE4A530 (link) were performed as previously described.
Most recents protocols related to «Radioimmunoassay»
Protocol full text hidden due to copyright restrictions
Open the protocol to access the free full text link
Perioperative indexes of the two groups (observation of intraoperative blood loss, operation time, and number of lymph node dissection). (2) Determination of tumor markers: after treatment, 5 ml of fasting elbow vein blood was drawn from the patient, the supernatant was centrifuged, and CYFRA21-1, CA125, as well as VGEF levels were measured by radioimmunoassay. (3) Immune function: after centrifugation of the above patients' serum, CD4+, CD3+, and CD4+/CD8+ were measured via flow cytometry (American BD company, FACS Vantage type). (4) Adverse reaction determination: record the occurrence of complications of the two groups of patients during treatment
Top products related to «Radioimmunoassay»
More about "Radioimmunoassay"
This method combines the specificity of antibody-antigen interactions with the sensitivity of radioactive isotope detection.
RIAs involve the use of a radioactively labeled analyte that competes with the unlabeled analyte from the sample for binding to a limited amount of specific antibody.
The amount of radioactive analyte bound to the antibody is inversly proportional to the concentration of the unlabeled analyte in the sample, allowing for accurate quantification.
This powerful technique has numerous applications in clinical diagnostics, pharmacology, and biochemical research, enabling precise measurement of a wide range of target analytes with high sensitivity and specificity.
Radioimmunoassay kits and Immulite 2000 are examples of commercially available RIA products that leverage this technology.
Researchers can optimize their RIA experiments by easily comparing protocols from literature, pre-prints, and patents to identify the best procedures and products for improved reproducibility and accuracy.
By leveraging the power of artificial intelligence, tools like PubCompare.ai can take the guesswork out of RIA research, enabling scientists to make more informed decisions and drive better outcomes.